What is the recommended diagnostic work‑up and management plan for serositis (pleuritis, pericarditis, or peritoneal inflammation)?

Approach to Serositis

For serositis presenting as pericarditis, initiate combination therapy with high-dose NSAIDs (aspirin 750-1000 mg every 8 hours or ibuprofen 600 mg every 8 hours) plus colchicine (0.5 mg once daily if <70 kg or twice daily if ≥70 kg) for 3 months, with gastroprotection, and reserve corticosteroids only for contraindications or treatment failure. 1

Initial Diagnostic Work-Up

Risk Stratification and Triage

Perform immediate risk assessment to determine admission need and extent of etiologic investigation. 1

Major risk factors requiring hospital admission and etiologic search include: 1

• High fever (>38°C/100.4°F)
• Subacute onset (symptoms over several days without clear-cut acute onset)
• Large pericardial effusion (diastolic echo-free space >20 mm)
• Cardiac tamponade
• Failure to respond within 7 days to NSAIDs

Minor risk factors also warranting admission: 1

• Myopericarditis
• Immunosuppression
• Trauma
• Oral anticoagulant therapy

Essential Diagnostic Tests for Pericarditis

Obtain the following baseline studies: 1

• Physical examination (assess for pericardial friction rub, present in <30% of cases) 2
• ECG (widespread ST-segment elevation and PR depression, present in 25-50% of cases) 2
• Chest X-ray
• Echocardiogram (pericardial effusion present in ~60% of cases) 2
• C-reactive protein (CRP) - essential for guiding treatment duration 1
• Troponin

Peritoneal Serositis Work-Up

For patients with ascites, perform diagnostic paracentesis immediately upon hospital admission, even without symptoms of infection. 1

Obtain ascitic fluid analysis including: 1

• Cell count with differential (PMN count >250/mm³ establishes diagnosis of spontaneous bacterial peritonitis)
• Bedside inoculation of at least 10 mL into aerobic and anaerobic blood culture bottles (increases sensitivity to >90%)
• Simultaneous blood cultures

If pleural effusion is present without ascites or when paracentesis rules out SBP but infection is suspected, perform diagnostic thoracentesis. 1

Management Algorithm

Low-Risk Pericarditis (No High-Risk Features)

Initiate outpatient management with empiric anti-inflammatory therapy. 1

First-line therapy (Class I, Level A recommendation): 1

• Aspirin 750-1000 mg every 8 hours OR Ibuprofen 600 mg every 8 hours
• PLUS Colchicine 0.5 mg once daily (<70 kg) or 0.5 mg twice daily (≥70 kg)
• PLUS gastroprotection
• Duration: 1-2 weeks for NSAIDs (symptoms and CRP-guided), 3 months for colchicine

Taper NSAIDs gradually: 1

• Aspirin: decrease by 250-500 mg every 1-2 weeks
• Ibuprofen: decrease by 200-400 mg every 1-2 weeks
• Continue until symptom resolution and CRP normalization

Monitor CRP to guide treatment length and assess response (Class IIa, Level C recommendation). 1

Moderate to High-Risk Cases

Admit for hospital-based etiologic investigation and treatment. 1

If specific etiology identified (tuberculosis, autoimmune disease, malignancy, purulent infection), treat the underlying cause. 1

For tuberculous pericarditis in endemic areas, initiate antituberculous therapy with consideration of corticosteroids for associated constrictive pericarditis. 2

Treatment Failure or Contraindications to First-Line Therapy

Consider low-to-moderate dose corticosteroids (prednisone 0.2-0.5 mg/kg/day) ONLY when: 1

• Contraindication to aspirin/NSAIDs and colchicine exists
• Failure of first-line therapy after adequate trial
• Infectious cause has been excluded
• Specific indication present (autoimmune disease, pregnancy, post-pericardiotomy syndrome)

Critical caveat: Corticosteroids are NOT recommended as first-line therapy (Class III, Level C) due to risk of promoting chronic disease evolution and drug dependence. 1

If corticosteroids are used, combine with colchicine and taper extremely slowly. 1

Recurrent Pericarditis

Recurrence is defined as: 1

• Documented first episode of acute pericarditis
• Symptom-free interval of 4-6 weeks or longer
• Evidence of subsequent recurrence by same diagnostic criteria

For first recurrence, continue colchicine for at least 6 months (not just 3 months). 1, 3

For multiple recurrences refractory to NSAIDs, colchicine, and corticosteroids, consider IL-1 blockers (anakinra, rilonacept, goflikicept) as third-line therapy or second-line in patients with contraindications to corticosteroids. 3, 2

Peritoneal Serositis Management

For spontaneous bacterial peritonitis (ascitic fluid PMN >250/mm³), initiate empiric IV antibiotics immediately before culture results: 1

• First-line in low MDRO prevalence settings: IV cefotaxime 2 g every 12 hours
• For nosocomial infection, recent hospitalization, or critically ill patients: Consider broader coverage with carbapenems due to multidrug-resistant organisms

Narrow antibiotic coverage once culture results available and treat for shortest effective duration (antibiotic stewardship). 1

For lupus-related serositis (pleuritis, pericarditis, peritonitis), NSAIDs are initially effective in 35% of cases, with moderate-to-high dose oral prednisolone required in 76% for both serositis and concomitant disease activity. 4

Activity Restriction

Restrict physical activity beyond ordinary sedentary life until resolution of symptoms and normalization of CRP, ECG, and echocardiogram (Class IIa, Level C). 1

For athletes specifically, mandate minimum 3-month restriction from competitive sports after symptom onset, even if symptoms resolve earlier. 1

For non-athletes, shorter restriction period (until remission) is acceptable. 1

Common Pitfalls to Avoid

Do not use high-dose corticosteroids (prednisone 1.0 mg/kg/day) - use only low-to-moderate doses (0.2-0.5 mg/kg/day) if corticosteroids are necessary. 1

Do not taper NSAIDs or corticosteroids rapidly (within 1 month) - this increases recurrence risk. 3

Do not omit colchicine from initial therapy - it reduces recurrence rate from 37.5% to 16.7% (absolute risk reduction 20.8%). 2

Do not delay paracentesis in hospitalized cirrhotic patients with ascites - perform emergently even without symptoms to rule out SBP. 1

Do not place chest tube for spontaneous bacterial empyema (pleural fluid PMN >250/mm³) - treat with antibiotics alone. 1

Do not assume viral/idiopathic etiology in endemic tuberculosis areas - maintain high index of suspicion and investigate appropriately. 1, 2